PAMELA HOPKINS: Open Payments
NPI 1558739375 · CLIO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$650 in 40 payments from 13 companies in 2025. Trend: 2023 $604 · 2024 $473 · 2025 $650
Food & beverage: $650
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $159 |
| Otsuka America Pharmaceutical, Inc. | 4 | $94 |
| PFIZER INC. | 4 | $69 |
| Exact Sciences Corporation | 2 | $53 |
| Vanda Pharmaceuticals Inc. | 2 | $49 |
| Novo Nordisk Inc | 2 | $42 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| Lundbeck LLC | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Axsome Therapeutics, Inc. | 1 | $23 |
Products named: REXULTI, VRAYLAR, NURTEC ODT, The Cologuard Plus Collection Kit, FANAPT, Ozempic, AUSTEDO XR, MAVYRET.
Industry payments across MI — which companies pay providers there.
